Concepedia

Y. H. Kim

YH

Statistics

Publications

1

Citations

40

H-Index

1

Active since

2006

Affiliations

Stanford University(Current)

Y. H. Kim is an author at Stanford University specializing in oncology pharmacotherapy, lymphoma treatment response, and clinical activity scoring.

Publications per year

2006–2006

1

Publications

1

Vorinostat (suberoylanilide hydroxamic acid, SAHA) is clinically active in advanced cutaneous T-cell lymphoma (CTCL): Results of a phase IIb trial

EGJ Olsen, Y. H. Kim, T. Kuzel et al. · Journal of Clinical Oncology · 2006 · 40 citations

, , +14

1–1 of 1